Trailing-twelve-month (TTM) revenue is $197,000 with a year-over-year growth of (31.12%). Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $15,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-13 |
| Q4 FY2025Period ended 2025-12-31 | $77,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-03-17 |
| Q1 FY2026Period ended 2026-03-31 | $15,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-14 |
| Q2 FY2026Period ended 2026-06-30 | $90,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-14 |
| TTM revenue | $197,000 |
Current P/S: $49,733,144 market capitalization ÷ $197,000 TTM revenue = 252.45x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T14:58:46.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $90000.00.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T15:02:00.918Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Product | $176,000 | $570,000 | $316,000 | $498,000 | $237,000 | $119,000 |
| Royalty | $30,000 | $153,000 | $144,000 |
$197,000
$197,000
(31.12%)
vs. $286,004.646 a year ago (TTM)
(18.30%)
5 Year compound annual growth rate
1 Year
(31.12%)
3 Year
(36.89%)
5 Year
(18.30%)
10 Year
N/A
15 Year
N/A
20 Year
N/A
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $200,000 | ($142,000) | (41.52%) |
| 2024 | $342,000 | ($312,000) | (47.71%) |
| 2023 | $654,000 | +$181,000 | +38.27% |
| 2022 | $473,000 | ($250,000) | (34.58%) |
| 2021 | $723,000 | +$517,000 | +250.97% |
TTM Growth
(31.12%)
3-Year CAGR
(36.89%)
5-Year CAGR
(18.30%)
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 21 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-06T15:02:00.918Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
| $105,000 |
| $81,000 |
